Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Bristol Myers Squibb
Biotech
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
A new analysis from Cytokinetics gives the first shot at a direct comparison between aficamten and BMS’ $13.1 billion heart disease drug Camzyos.
Nick Paul Taylor
May 13, 2024 9:36am
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
May 10, 2024 8:30am
BMS pays $65M to expand Repertoire of autoimmune assets
Apr 29, 2024 6:15am
BMS closes Redwood City cell therapy research site
Apr 26, 2024 10:59am
BMS plans $1.5B in cuts through '25, with 2,000-plus layoffs
Apr 25, 2024 8:40am
Geopolitics threatens Chinese biotechs' hot out-licensing biz
Apr 11, 2024 4:00am